This may indicate indirect or compensatory signaling interplay rather than a direct IL6-FOXO4 linkage, highlighting the complex network through which CDD exerts its therapeutic effects in PCOS. The gene discussed is IL6; the disease is craniodiaphyseal dysplasia.